Clinical Trial Update: A Study on Multimodal Prognostic Scoring of Advanced PDAC.

View source ↗

Summary

A clinical trial evaluating multimodal prognostic scoring for advanced pancreatic ductal adenocarcinoma is currently enrolling by invitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Ductal Adenocarcinoma

Snippet

Sponsor: RenJi Hospital | Conditions: Pancreatic Ductal Adenocarcinoma (PDAC) | Status: ENROLLING_BY_INVITATION